These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32155117)

  • 1. PHF19 mediated regulation of proliferation and invasiveness in prostate cancer cells.
    Jain P; Ballare C; Blanco E; Vizan P; Di Croce L
    Elife; 2020 Mar; 9():. PubMed ID: 32155117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formation.
    Ren Z; Ahn JH; Liu H; Tsai YH; Bhanu NV; Koss B; Allison DF; Ma A; Storey AJ; Wang P; Mackintosh SG; Edmondson RD; Groen RWJ; Martens AC; Garcia BA; Tackett AJ; Jin J; Cai L; Zheng D; Wang GG
    Blood; 2019 Oct; 134(14):1176-1189. PubMed ID: 31383640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An H3K36 methylation-engaging Tudor motif of polycomb-like proteins mediates PRC2 complex targeting.
    Cai L; Rothbart SB; Lu R; Xu B; Chen WY; Tripathy A; Rockowitz S; Zheng D; Patel DJ; Allis CD; Strahl BD; Song J; Wang GG
    Mol Cell; 2013 Feb; 49(3):571-82. PubMed ID: 23273982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Dimeric Structural Scaffold for PRC2-PCL Targeting to CpG Island Chromatin.
    Chen S; Jiao L; Liu X; Yang X; Liu X
    Mol Cell; 2020 Mar; 77(6):1265-1278.e7. PubMed ID: 31959557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of PHF19 inhibits cell growth and migration in gastric cancer.
    Wang H; Xu P; Sun G; Lv J; Cao J; Xu Z
    Scand J Gastroenterol; 2020 Jun; 55(6):687-693. PubMed ID: 32449434
    [No Abstract]   [Full Text] [Related]  

  • 6. Structural basis for histone variant H3tK27me3 recognition by PHF1 and PHF19.
    Dong C; Nakagawa R; Oyama K; Yamamoto Y; Zhang W; Dong A; Li Y; Yoshimura Y; Kamiya H; Nakayama JI; Ueda J; Min J
    Elife; 2020 Sep; 9():. PubMed ID: 32869745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycomb PHF19 binds H3K36me3 and recruits PRC2 and demethylase NO66 to embryonic stem cell genes during differentiation.
    Brien GL; Gambero G; O'Connell DJ; Jerman E; Turner SA; Egan CM; Dunne EJ; Jurgens MC; Wynne K; Piao L; Lohan AJ; Ferguson N; Shi X; Sinha KM; Loftus BJ; Cagney G; Bracken AP
    Nat Struct Mol Biol; 2012 Dec; 19(12):1273-81. PubMed ID: 23160351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancer.
    Ghamlouch H; Boyle EM; Blaney P; Wang Y; Choi J; Williams L; Bauer M; Auclair D; Bruno B; Walker BA; Davies FE; Morgan GJ
    J Exp Clin Cancer Res; 2021 Dec; 40(1):380. PubMed ID: 34857028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PHF19 promotes the proliferation, migration, and chemosensitivity of glioblastoma to doxorubicin through modulation of the SIAH1/β-catenin axis.
    Deng Q; Hou J; Feng L; Lv A; Ke X; Liang H; Wang F; Zhang K; Chen K; Cui H
    Cell Death Dis; 2018 Oct; 9(11):1049. PubMed ID: 30323224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycomb-like Proteins in Gene Regulation and Cancer.
    Fischer S; Liefke R
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PHF19 inhibition as a therapeutic target in multiple myeloma.
    Schinke CD; Bird JT; Qu P; Yaccoby S; Lyzogubov VV; Shelton R; Ling W; Boyle EM; Deshpande S; Byrum SD; Washam C; Mackintosh S; Stephens O; Thanendrarajan S; Zangari M; Shaughnessy J; Zhan F; Barlogie B; van Rhee F; Walker BA
    Curr Res Transl Med; 2021 Jul; 69(3):103290. PubMed ID: 33894670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycomb-like proteins link the PRC2 complex to CpG islands.
    Li H; Liefke R; Jiang J; Kurland JV; Tian W; Deng P; Zhang W; He Q; Patel DJ; Bulyk ML; Shi Y; Wang Z
    Nature; 2017 Sep; 549(7671):287-291. PubMed ID: 28869966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycomb Factor PHF19 Controls Cell Growth and Differentiation Toward Erythroid Pathway in Chronic Myeloid Leukemia Cells.
    García-Montolio M; Ballaré C; Blanco E; Gutiérrez A; Aranda S; Gómez A; Kok CH; Yeung DT; Hughes TP; Vizán P; Di Croce L
    Front Cell Dev Biol; 2021; 9():655201. PubMed ID: 33996816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8
    Ji Y; Fioravanti J; Zhu W; Wang H; Wu T; Hu J; Lacey NE; Gautam S; Le Gall JB; Yang X; Hocker JD; Escobar TM; He S; Dell'Orso S; Hawk NV; Kapoor V; Telford WG; Di Croce L; Muljo SA; Zhang Y; Sartorelli V; Gattinoni L
    Nat Commun; 2019 May; 10(1):2157. PubMed ID: 31089138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phf19 links methylated Lys36 of histone H3 to regulation of Polycomb activity.
    Ballaré C; Lange M; Lapinaite A; Martin GM; Morey L; Pascual G; Liefke R; Simon B; Shi Y; Gozani O; Carlomagno T; Benitah SA; Di Croce L
    Nat Struct Mol Biol; 2012 Dec; 19(12):1257-65. PubMed ID: 23104054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycomb-like Protein 3 Induces Proliferation and Drug Resistance in Multiple Myeloma and Is Regulated by miRNA-15a.
    Yu T; Du C; Ma X; Sui W; Yu Z; Liu L; Zhao L; Li Z; Xu J; Wei X; Zhou W; Deng S; Zou D; An G; Tai YT; Tricot G; Anderson KC; Qiu L; Zhan F; Hao M
    Mol Cancer Res; 2020 Jul; 18(7):1063-1073. PubMed ID: 32312841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of the oncogenic transcription factor ERG in prostate cells dissociates polycomb repressive complex 2, allowing target gene activation.
    Kedage V; Strittmatter BG; Dausinas PB; Hollenhorst PC
    J Biol Chem; 2017 Oct; 292(42):17225-17235. PubMed ID: 28887309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EWS/ETS-Driven Ewing Sarcoma Requires BET Bromodomain Proteins.
    Gollavilli PN; Pawar A; Wilder-Romans K; Natesan R; Engelke CG; Dommeti VL; Krishnamurthy PM; Nallasivam A; Apel IJ; Xu T; Qin ZS; Feng FY; Asangani IA
    Cancer Res; 2018 Aug; 78(16):4760-4773. PubMed ID: 29898995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer.
    Hoffmann MJ; Engers R; Florl AR; Otte AP; Muller M; Schulz WA
    Cancer Biol Ther; 2007 Sep; 6(9):1403-12. PubMed ID: 18637271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tudor domains of the PRC2 components PHF1 and PHF19 selectively bind to histone H3K36me3.
    Qin S; Guo Y; Xu C; Bian C; Fu M; Gong S; Min J
    Biochem Biophys Res Commun; 2013 Jan; 430(2):547-53. PubMed ID: 23228662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.